Actualités quotidiennes

한국의 1차·2차·3차 의료 체계가 설명되지만, 약국 현장에서 체계의 실효성에 대한 의문이 제기된다.

Fierce Pharma invites nominations of early‑career marketing professionals to be featured in its Rising Stars Q&A series.

Innoviva has launched Nortiva Bio, using rescued Langer Lab assets to develop long‑acting oral medicines and seek drug development alliances.

The World Health Organization honors Dr. David Nabarro for his contributions to global health.

WHO Director-General Dr Tedros Adhanom Ghebreyesus concluded the first day of his state visit to Jordan, emphasizing collaboration on universal health coverage, mental health and humanitarian health initiatives.

Pfizer announced CFO Dave Denton will exit in August, with senior finance VP Cecile Guegan stepping in as interim CFO.

The Seongdong-gu Pharmaceutical Society and its Women’s Committee delivered cash, first‑aid medicines and purchased a workshop‑made item for the Seongmo Protection Workshop, supporting 34 individuals with intellectual disabilities.

CEO pay rankings at major pharma firms were revised, with some executives seeing large increases tied to robust sales, while others fell due to reduced stock awards and market shifts.

Yuhan Corp, a leading Korean pharma and biotech firm, marked its centennial on the 20th, emphasizing its founder’s philosophy of profit reinvestment into society via the Yuhan Foundation and Yuhan Academy.

JW중외제약이 지난해 도입한 비주력 제네릭 CSO 영업대행 사업을 수익성·효율성 부진으로 1년여 만에 철수한다.

The mother of Seong-yeong Joon, 27th auditor of Chosun University College of Pharmacy alumni association and Gyeonggi-do Pharmaceutical Association vice‑president, died at 91. Funeral details are provided.

Novo Nordisk will begin manufacturing next‑generation diabetes and obesity drug ingredients at its recently acquired Czech Republic plant and announced a $29 million upgrade to its China facility.